May 10 (Reuters) - Valeant Pharmaceuticals International Inc (NYSE:VRX)
* Files for non-timely 10-Q - SEC filing
* Does not expect that it will be in a position to file the
form 10-Q within the 5-day extension period provided in rule
12b-25(b)
* Currently in process of completing preparation of
financial statements for fiscal quarter ended March 31
* Due to "concentration of resources" on restating
financials, unable to file form 10-Q for quarter ended march 31
within prescribed time period
Source text: http://1.usa.gov/1TzqiSk
Further company coverage: [ ]